Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey

Abstract Helicobacter pylori colonizes the gastric mucosa of about half of the world’s population, causing chronic gastritis and gastric cancer. An increasing emergence of antibiotic-resistant H. pylori arouses demand on alternative non-antibiotic-based therapies. In this study, we freshly prepared...

Full description

Bibliographic Details
Main Authors: Dong-Jae Kim, Min-Jung Kang, Jin-A Choi, Dae-Seung Na, Jin-Beom Kim, Chun-Soo Na, Jong-Hwan Park
Format: Article
Language:English
Published: BMC 2016-12-01
Series:Laboratory Animal Research
Subjects:
Online Access:http://link.springer.com/article/10.5625/lar.2016.32.2.99
_version_ 1818159732322467840
author Dong-Jae Kim
Min-Jung Kang
Jin-A Choi
Dae-Seung Na
Jin-Beom Kim
Chun-Soo Na
Jong-Hwan Park
author_facet Dong-Jae Kim
Min-Jung Kang
Jin-A Choi
Dae-Seung Na
Jin-Beom Kim
Chun-Soo Na
Jong-Hwan Park
author_sort Dong-Jae Kim
collection DOAJ
description Abstract Helicobacter pylori colonizes the gastric mucosa of about half of the world’s population, causing chronic gastritis and gastric cancer. An increasing emergence of antibiotic-resistant H. pylori arouses demand on alternative non-antibiotic-based therapies. In this study, we freshly prepared crude N-acetylneuraminic acid obtained from glycomacropeptide (G-NANA) of whey through a neuraminidase-mediated reaction and evaluated its antibacterial ability against H. pylori and H. felis. Overnight cultures of the H. pylori were diluted with fresh media and different concentrations (1-150 mg/mL) of crude G-NANA were added directly to the culture tube. Bacterial growth was evaluated by measuring the optical density of the culture medium and the number of viable bacteria was determined by a direct count of the colony forming units (CFU) on agar plates. For the in vivo study, mice were orally infected with 100 μL (5×108 cfu/mL) of H. felis four times at a day’s interval, accompanied by a daily administration of crude G-NANA or vehicle. A day after the last infection, the mice were daily administered the crude G-NANA (0, 75, and 300 mg/mL) for 10 days and euthanized. Their stomachs were collected and bacterial colonization was determined by quantitative real-time PCR. Crude G-NANA inhibited H. pylori’s growth and reduced the number of viable bacteria in a dose-dependent manner. Furthermore, crude G-NANA inhibited bacterial colonization in the mice. These results showed that crude G-NANA has antibacterial activity against Helicobacter and demonstrated its therapeutic potential for the prevention of chronic gastritis and gastric carcinogenesis induced by Helicobacter infection in humans.
first_indexed 2024-12-11T15:50:39Z
format Article
id doaj.art-007dd573a7ce4760b0ffd58301f05604
institution Directory Open Access Journal
issn 2233-7660
language English
last_indexed 2024-12-11T15:50:39Z
publishDate 2016-12-01
publisher BMC
record_format Article
series Laboratory Animal Research
spelling doaj.art-007dd573a7ce4760b0ffd58301f056042022-12-22T00:59:35ZengBMCLaboratory Animal Research2233-76602016-12-013229910410.5625/lar.2016.32.2.99Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of wheyDong-Jae Kim0Min-Jung Kang1Jin-A Choi2Dae-Seung Na3Jin-Beom Kim4Chun-Soo Na5Jong-Hwan Park6Laboratory Animal Resource Center, Daegu Gyeongbuk Institute of Science & Technology (DGISTLaboratory Animal Medicine and Brain Korea 21 PLUS Project, College of Veterinary Medicine, Chonnam National UniversityDepartment of Biochemistry, College of Medicine, Konyang UniversityLifetree Biotechnology Institute, Lifetree Bitotech Co. Ltd.Lifetree Biotechnology Institute, Lifetree Bitotech Co. Ltd.Lifetree Biotechnology Institute, Lifetree Bitotech Co. Ltd.Laboratory Animal Medicine and Brain Korea 21 PLUS Project, College of Veterinary Medicine, Chonnam National UniversityAbstract Helicobacter pylori colonizes the gastric mucosa of about half of the world’s population, causing chronic gastritis and gastric cancer. An increasing emergence of antibiotic-resistant H. pylori arouses demand on alternative non-antibiotic-based therapies. In this study, we freshly prepared crude N-acetylneuraminic acid obtained from glycomacropeptide (G-NANA) of whey through a neuraminidase-mediated reaction and evaluated its antibacterial ability against H. pylori and H. felis. Overnight cultures of the H. pylori were diluted with fresh media and different concentrations (1-150 mg/mL) of crude G-NANA were added directly to the culture tube. Bacterial growth was evaluated by measuring the optical density of the culture medium and the number of viable bacteria was determined by a direct count of the colony forming units (CFU) on agar plates. For the in vivo study, mice were orally infected with 100 μL (5×108 cfu/mL) of H. felis four times at a day’s interval, accompanied by a daily administration of crude G-NANA or vehicle. A day after the last infection, the mice were daily administered the crude G-NANA (0, 75, and 300 mg/mL) for 10 days and euthanized. Their stomachs were collected and bacterial colonization was determined by quantitative real-time PCR. Crude G-NANA inhibited H. pylori’s growth and reduced the number of viable bacteria in a dose-dependent manner. Furthermore, crude G-NANA inhibited bacterial colonization in the mice. These results showed that crude G-NANA has antibacterial activity against Helicobacter and demonstrated its therapeutic potential for the prevention of chronic gastritis and gastric carcinogenesis induced by Helicobacter infection in humans.http://link.springer.com/article/10.5625/lar.2016.32.2.99N-neuraminic acidglycomacropeptideHelicobacterantibacterial activity
spellingShingle Dong-Jae Kim
Min-Jung Kang
Jin-A Choi
Dae-Seung Na
Jin-Beom Kim
Chun-Soo Na
Jong-Hwan Park
Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey
Laboratory Animal Research
N-neuraminic acid
glycomacropeptide
Helicobacter
antibacterial activity
title Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey
title_full Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey
title_fullStr Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey
title_full_unstemmed Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey
title_short Anti-Helicobacter pylori activity of crude N-acetylneuraminic acid isolated from glycomacropeptide of whey
title_sort anti helicobacter pylori activity of crude n acetylneuraminic acid isolated from glycomacropeptide of whey
topic N-neuraminic acid
glycomacropeptide
Helicobacter
antibacterial activity
url http://link.springer.com/article/10.5625/lar.2016.32.2.99
work_keys_str_mv AT dongjaekim antihelicobacterpyloriactivityofcrudenacetylneuraminicacidisolatedfromglycomacropeptideofwhey
AT minjungkang antihelicobacterpyloriactivityofcrudenacetylneuraminicacidisolatedfromglycomacropeptideofwhey
AT jinachoi antihelicobacterpyloriactivityofcrudenacetylneuraminicacidisolatedfromglycomacropeptideofwhey
AT daeseungna antihelicobacterpyloriactivityofcrudenacetylneuraminicacidisolatedfromglycomacropeptideofwhey
AT jinbeomkim antihelicobacterpyloriactivityofcrudenacetylneuraminicacidisolatedfromglycomacropeptideofwhey
AT chunsoona antihelicobacterpyloriactivityofcrudenacetylneuraminicacidisolatedfromglycomacropeptideofwhey
AT jonghwanpark antihelicobacterpyloriactivityofcrudenacetylneuraminicacidisolatedfromglycomacropeptideofwhey